Anthracycline dose intensification in acute myeloid leukemia

New England Journal of Medicine

Volumn 361, Issue 26, 2009, Pages 2578-

  Naina, Harris V K ^a   Patnaik, Mrinal M ^a   Harris, Samar ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MISSOURI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; CYTARABINE;

ACUTE GRANULOCYTIC LEUKEMIA; CLINICAL PRACTICE; CYTOGENETICS; DRUG DOSE REGIMEN; DRUG MEGADOSE; HEALTH INSURANCE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; LETTER; PRIORITY JOURNAL; RISK ASSESSMENT;

EID: 73549123854     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc0910366     Document Type: Letter

References (1)

1. Fernandez HF, Sun Z, Yao X, et al. Anthracycline dose intensification in acute myeloid leukemia. N Engl J Med 2009;361:1249-59.